Data as of Sep 19, 2026 · Based on 3,321,027 AI responses across 10,525 prompts · See how Parse measures this
4 of 5 measured questions
DCVC Bio is a deep-tech life sciences venture capital firm established in 2018 that invests in companies applying frontier biology and compute to advance human health, agriculture, and synthetic biology. Its team combines scientific expertise in genetics, chemistry, molecular biology, and AI with operating experience to back long‑term ventures solving hard problems. The portfolio includes AbCellera, Umoja Biopharma, Elo Life, and MycoWorks, among others, with a focus on translating breakthroughs into accessible medicines and sustainable biotechnologies.
The market map · 5 of 100 labelled
Deep Tech Venture Capital Firms →Where DCVC Bio ranks in AI